Convalescent plasma in the management of moderate covid-19 in adults in India: open label phase II multicentre randomised controlled trial (PLACID Trial)
Unknown authors
Abstract
the citation for reference 28 should appear at the end of the first paragraph of the strengths and limitations section of the discussion: "Although this approach could have affected comparability across study sites, we believe this lends the trial more generalisability, approximates real world scenarios more closely, and in the methodological spectrum of clinical trials, shifts it towards pragmatic trials.
Topics & Concepts
Coronavirus disease 2019 (COVID-19)MedicineOpen labelSevere acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Convalescent plasma2019-20 coronavirus outbreakPhase (matter)Randomized controlled trialClinical trialInternal medicineVirologyOutbreakDiseaseInfectious disease (medical specialty)Organic chemistryChemistryCOVID-19 Clinical Research Studies